1. Amoxicillin-induced aseptic meningitis

   News item 28 May 2022 Pages: 1 - 1

2. Batch of mefenamic acid recalled by Quadrant Pharmaceuticals

   News item 28 May 2022 Pages: 2 - 2

3. Sulfonamide diuretics increase risk of eye disorders

   News item 28 May 2022 Pages: 3 - 3

4. Warfarin-related nephropathy

   News item 28 May 2022 Pages: 4 - 4

5. ADR reporting rate greater for valsartan than other ARBs

   Clinical study 28 May 2022 Pages: 5 - 5

6. Concurrent use of prescribed drugs with risk of MACE further increases risk

   Clinical study 28 May 2022 Pages: 6 - 6

7. Fourth-dose boosters with COVID-19 mRNA vaccines well tolerated

   Clinical study 28 May 2022 Pages: 7 - 7

8. Higher paracetamol doses due to errors safe in critically ill children

   Clinical study 28 May 2022 Pages: 8 - 8

9. Hydroxychloroquine concentrations persist after drug discontinuation

   Clinical study 28 May 2022 Pages: 9 - 9

10. Machine learning-based model predicts causal association of ADRs

    Clinical study 28 May 2022 Pages: 10 - 10

11. Pfizer-BioNTech COVID-19 vaccine safe in children

    Clinical study 28 May 2022 Pages: 11 - 11

12. Signal validation process improved by ML-based decision support

    Clinical study 28 May 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 28 May 2022 Pages: 13 - 13

14. Abacavir/lamivudine/raltegravir

    Case report 28 May 2022 Pages: 14 - 14

15. Abemaciclib/denosumab/fulvestrant

    Case report 28 May 2022 Pages: 15 - 15

16. Abiraterone/docetaxel/olaparib

    Case report 28 May 2022 Pages: 16 - 16

17. Acalabrutinib

    Case report 28 May 2022 Pages: 17 - 17

18. Acenocoumarol/dabigatran-etexilate

    Case report 28 May 2022 Pages: 18 - 18

19. Ad26.cov2-s

    Case report 28 May 2022 Pages: 19 - 19

20. Adalimumab

    Case report 28 May 2022 Pages: 20 - 20

21. Adalimumab/Certolizumab-pegol

    Case report 28 May 2022 Pages: 21 - 21

22. Adalimumab/infliximab

    Case report 28 May 2022 Pages: 22 - 22

23. Adenosine

    Case report 28 May 2022 Pages: 23 - 23

24. Afatinib

    Case report 28 May 2022 Pages: 24 - 24

25. Agalsidase-beta

    Case report 28 May 2022 Pages: 25 - 25

26. Aldesleukin/gefitinib/regorafenib

    Case report 28 May 2022 Pages: 26 - 26

27. Alectinib

    Case report 28 May 2022 Pages: 27 - 27

28. Alemtuzumab

    Case report 28 May 2022 Pages: 28 - 28

29. Alemtuzumab

    Case report 28 May 2022 Pages: 29 - 29

30. Alendronic-acid

    Case report 28 May 2022 Pages: 30 - 30

31. Amiodarone

    Case report 28 May 2022 Pages: 31 - 31

32. Amiodarone

    Case report 28 May 2022 Pages: 32 - 32

33. Amiodarone

    Case report 28 May 2022 Pages: 33 - 33

34. Amiodarone

    Case report 28 May 2022 Pages: 34 - 34

35. Amiodarone

    Case report 28 May 2022 Pages: 35 - 35

36. Amiodarone

    Case report 28 May 2022 Pages: 36 - 36

37. Amiodarone/camrelizumab/nifekalant

    Case report 28 May 2022 Pages: 37 - 37

38. Amiodarone/mexiletine/sotalol

    Case report 28 May 2022 Pages: 38 - 38

39. Amiodarone/nitrofurantoin

    Case report 28 May 2022 Pages: 39 - 39

40. Amisulpride/olanzapine/risperidone

    Case report 28 May 2022 Pages: 40 - 40

41. Amlodipine/aspirin/carvedilol

    Case report 28 May 2022 Pages: 41 - 41

42. Amlodipine/iron-gluconate

    Case report 28 May 2022 Pages: 42 - 42

43. Amoxicillin/clavulanic-acid

    Case report 28 May 2022 Pages: 43 - 43

44. Amoxicillin/clavulanic-acid

    Case report 28 May 2022 Pages: 44 - 44

45. Amoxicillin/hydrocortisone/sodium-chloride

    Case report 28 May 2022 Pages: 45 - 45

46. Amphotericin B/cytarabine

    Case report 28 May 2022 Pages: 46 - 46

47. Amphotericin-B-liposomal

    Case report 28 May 2022 Pages: 47 - 47

48. Amphotericin-B/fluconazole/voriconazole

    Case report 28 May 2022 Pages: 48 - 48

49. Amphotericin-B/terbinafine/voriconazole

    Case report 28 May 2022 Pages: 49 - 49

50. Anti-inflammatories/mycophenolate mofetil

    Case report 28 May 2022 Pages: 50 - 50